Pharmaceutical products

Tender description

Invitation to offer for NHS National Generic Pharmaceuticals — Interim Offer Reference Number: CM/PHG/18/5574 Period of Framework Agreement: Dates detailed below with options to extend up to a maximum period of 38 months. Potential periods of call-offs under the Framework Agreement: Oral products: all regions 1.8.2019 to 28.2.2021 (19 months) Hospital only products: LSNE: 1.8.2019 to 31.1.2020 (6 months); NWLN: 1.8.2019 to 31.1.2020 (6 months); CESW: 1.8.2019 to 31.1.2020 (6 months). NHS National Generic Pharmaceuticals — Interim (hospital only products — LSNE Region) Offer Reference Number: CM/PHG/18/5574/02 Period of Framework Agreement: dates detailed below with options to extend to a maximum period of 12 months. Potential periods of call-offs under the Framework Agreement: Hospital Only Products: LSNE Region 1.8.2019 to 30.1.2020 (6 months). NHS National Generic Pharmaceuticals — Interim (oral products — all regions) Offer Reference Number: CM/PHG/18/5574/01 Period of Framework Agreement: dates detailed below with options to extend to a maximum period of 38 months. Potential periods of call-offs under the Framework Agreement: Oral products: all regions 1.8.2019 to 28.2.2021 (19 months). NHS National Generic Pharmaceuticals — Interim (Hospital only products — NWLN Region) Offer Reference Number: CM/PHG/18/5574/02 Period of Framework Agreement: dates detailed below with options to extend to a maximum period of 12 months. Potential periods of call-offs under the Framework Agreement: Hospital only products: NWLN Region 1.8.2019 to 30.1.2020 (6 months). NHS National Generic Pharmaceuticals — Interim (hospital only products — CESW Region) Offer Reference Number: CM/PHG/18/5574/02 Period of Framework Agreement: dates detailed below with options to extend to a maximum period of 12 months. Potential periods of call-offs under the Framework Agreement: Hospital only products: CESW Region 1.8.2019 to 30.1.2020 (6 months).